Tetherex
Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer... Read moreTetherex
Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer... Read more
News
Jul 09, 2021
FinanzNachrichten
Tetherex: Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia
Jul 06, 2021
BioSpace
Tetherex: Tetherex Pharmaceuticals Signs Exclusive Worldwide License with Mayo Clinic for Development and Commercialization of a Novel Single-Cycle Adenovirus Vaccine Platform
Oct 07, 2018
BioPortfolio
Tetherex Pharmaceuticals: Tetherex Pharmaceuticals Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Apr 19, 2018
Tulsa World
Tetherex Pharmaceuticals: Oklahoma City-based biotech company raises $50 million for clinical trials
Tetherex Competitors
1
2
3
4
5
6
7
8
9
10